RxDoctor Payments Data

Susan Elliott

Anesthesiology · Atlanta, GANPI 1669134029

Payments from drug & device makers

$2,057in general payments, 2019–2025

Across 48 payments — averaging $42.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$724
  • Curonix LLC$492
  • Nevro Corp.$328
  • Collegium Pharmaceutical, Inc.$155
  • Virtus Pharmaceuticals LLC$71
  • Scilex Pharmaceuticals Inc.$67
  • plus $220 from 6 others

What the payments were for

  • Travel & lodging$51925%
  • Food & beverage$1,49373%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,057 in reported general payments places this provider in the 90th percentile of 1,137 anesthesiology providers in Georgia.

See all anesthesiology providers in Georgia

Medicare billing

Part B allowed, 2024
$70,235
Medicare patients
174
Services billed
673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen741$80,703
BelbucaBuprenorphine Hcl74$52,739
NucyntaTapentadol Hcl42$52,558
Xtampza ErOxycodone Myristate67$46,527
OxycontinOxycodone Hcl36$26,686
Buprenorphine151$24,453
Nucynta ErTapentadol Hcl11$23,630
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen643$20,816
LinzessLinaclotide27$18,478
ZtlidoLidocaine11$6,478
Gabapentin313$5,371
Pregabalin177$4,936
Tramadol Hcl319$3,890
Lidocaine30$3,139
Tizanidine Hcl120$3,055

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er, Nucynta Er$155$175,454194 claims
Scilex Pharmaceuticals Inc.Ztlido$67$6,47811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,137 anesthesiology providers in Georgia.

Other anesthesiology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →